SYN-125

N/A

Report date: 2024/09/19 14:10:01

Base Information

Drug NameSYN-125
Drug Alias NameSYN-125
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT lymphocytes stimulantsAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursCarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynermore Biologics (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSynermore Biologics (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A